Overall, this study provides new insights into the effects of IL17A in modulating the intensity of both antigen‐specific humoral and cellular responses and the anti‐tumour response induced by a DNA anti‐cancer vaccine in pancreatic cancer. The gene discussed is IL17A; the disease is familial pancreatic carcinoma.